MedTrace Logo

AI-Based Tai Chi and Baduanjin for Improving Balance and Reducing Fall Risk in Adults With Chronic Diseases

NCT07672704 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-06-29

No results posted yet for this study

Summary

This study aims to examine the effects of an AI-based mobile application delivering Tai Chi and Baduanjin exercises on balance and fall risk in adults with chronic diseases.

Participants will be randomly assigned to Tai Chi, Baduanjin, or a control group over a 12-week period. The AI application will provide exercise guidance and basic feedback.

Outcomes will focus on balance and, fall risk, along with user interaction with the technology.

The results are expected to support the use of AI-assisted exercise programs in improving balance and reducing fall risk in individuals with chronic conditions.

Conditions

Interventions

BEHAVIORAL

Tai Chi Exercise Program

Participants will perform Tai Chi exercises guided by an AI-based mobile application. The program includes structured exercise sessions aimed at improving balance and mobility, with basic feedback provided by the application.

BEHAVIORAL

Baduanjin Exercise Program

Participants will perform Baduanjin exercises guided by an AI-based mobile application. The program consists of structured movements designed to support balance and physical function, with feedback delivered through the application.

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Mohamed Fakhry Ahmed Salem, PhD in Medical-Surgical Nursin · Alexandria University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-16
Primary Completion
2026-07-20
Completion
2026-07-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07672704 on ClinicalTrials.gov